FORM DEF 14A

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

August 23, 2018

Period of Report

October 12, 2018

Accession Number

0001437749-18-016024

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →